0001127602-22-003243.txt : 20220203 0001127602-22-003243.hdr.sgml : 20220203 20220203182551 ACCESSION NUMBER: 0001127602-22-003243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fong Ivan K CENTRAL INDEX KEY: 0001342238 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 22590118 MAIL ADDRESS: STREET 1: 3M CENTER CITY: ST. PAUL STATE: MN ZIP: 55144-1000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0429 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-02-01 0001613103 Medtronic plc MDT 0001342238 Fong Ivan K 710 MEDTRONIC PARKWAY LC300 MINNEAPOLIS MN 55432 1 EVP GENERAL COUNSEL & SECR Ordinary Shares 2022-02-01 4 A 0 6237 0 A 6237 D Ordinary Shares 2022-02-01 4 A 0 24134 0 A 30371 D Stock Option (Right to Buy) 103.59 2022-02-01 4 A 0 50476 103.59 A 2022-08-02 2031-08-02 Ordinary Shares 50476 50476 D Performance Share Units 2022-02-01 4 A 0 15591 0 A Performance Share Units 15591 15591 D Stock Option (Right to Buy) 103.59 2022-02-01 4 A 0 145852 103.59 A 2023-02-01 2032-02-01 Ordinary Shares 145852 145852 D Performance Share Units 2022-02-01 4 A 0 21238 0 A Performance Share Units 21238 21238 D The restrictions on these restricted stock units shall lapse 100% on August 2, 2024. The restrictions on these restricted stock units shall vest 50% on December 10, 2022, 25% on December 10, 2023 and 25% on December 10, 2024. These options become exercisable at the rate of 25% of the shares granted per year beginning on the date noted. Each performance share unit represents a contingent right to receive one share of Medtronic common stock. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,591 shares will be issued. The actual number of shares to be issued could range from a low of 3,118 at minimum performance to a high of 31,182 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Vests on August 2, 2024. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,238 shares will be issued. The actual number of shares to be issued could range from a low of 4,248 at minimum performance to a high of 42,476 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. /s/ Thomas L. Osteraas, attorney-in-fact 2022-02-03